RE Coleman

8.9k total citations · 1 hit paper
172 papers, 6.1k citations indexed

About

RE Coleman is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, RE Coleman has authored 172 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 65 papers in Radiology, Nuclear Medicine and Imaging and 58 papers in Pulmonary and Respiratory Medicine. Recurrent topics in RE Coleman's work include Bone health and treatments (56 papers), Radiopharmaceutical Chemistry and Applications (35 papers) and Medical Imaging Techniques and Applications (30 papers). RE Coleman is often cited by papers focused on Bone health and treatments (56 papers), Radiopharmaceutical Chemistry and Applications (35 papers) and Medical Imaging Techniques and Applications (30 papers). RE Coleman collaborates with scholars based in United Kingdom, United States and Belgium. RE Coleman's co-authors include RD Rubens, Michael J. Welch, Mathew L. Thakur, Edward F. Patz, Val J. Lowe, J. Heinrich Joist, Walter G. Wolfe, Francis G. Duhaylongsod, Anna Vaughn and Ingrid S. Synan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Circulation Research.

In The Last Decade

RE Coleman

169 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The clinical course of bone metastases from breast cancer

1987 869 citations RE Coleman, RD Rubens British Journal of Cancer profile →

Peers

Countries citing papers authored by RE Coleman

Since Specialization

Citations

This map shows the geographic impact of RE Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE Coleman more than expected).

Fields of papers citing papers by RE Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RE Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE Coleman. The network helps show where RE Coleman may publish in the future.

Co-authorship network of co-authors of RE Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of RE Coleman. A scholar is included among the top collaborators of RE Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RE Coleman. RE Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Potential of Monoclonal Antibodies as Carriers of Radiation and Drugs for Immunodetection and Therapy of Brain Tumors 2015 ·Progress in tumor research ·Mario A. Bourdon, RE Coleman, Darell D. Bigner	0
2	Current Opinion of Aromatase Inhibitor-induced Arthralgia in Breast Cancer in the UK 2011 ·Clinical Oncology ·Omar Din, David Dodwell, Matthew Winter, Shinobu Mori, RE Coleman	8
3	Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel 2010 ·Cancer Treatment Reviews ·Olaf Ortmann, Olivia Pagani, Andrew Jones, Nicolaì Maass, (unknown), Hope S. Rugo, CJH van de Velde, Matti Aapro, RE Coleman	22
4	The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease 2007 ·Calcified Tissue International ·J. E. Brown, Eugène McCloskey, J Dewar, Jean‐Jacques Body, David Cameron, A.N. Harnett, Mirja Ruutu, O.P. Purohit, Riitta Tähtelä, RE Coleman	20
5	Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer. 2006 ·Breast Cancer Research and Treatment ·C. J. Poole, Louise Hiller, Helen Howard, Shrushma Loi, Janet Dunn, (unknown), Andrew Wardley, John Crown, RE Coleman, Mark Verrill, Peter Ellis, Robert Leonard, D. Spooner, Helena Earl	1
6	On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma 2004 ·JNCI Journal of the National Cancer Institute ·(unknown), Gordon C. Jayson, Amanda Gordon, Hani Gabra, RE Coleman, (unknown), David E. Parkin, James Paul, (unknown), (unknown)	100
7	The detection of circulating breast cancer cells in blood 2004 ·Journal of Clinical Pathology ·(unknown), David Burnett, RE Coleman, Ingunn Holen	61
8	Chemotherapy, Erythropoietin and Bloodless Surgery in a Jehovah's Witness 2003 ·Clinical Oncology ·James E. Brown, M. Hatton, (unknown), Peter Goldstraw, RE Coleman	1
9	OPG is a survival factor for breast- and prostate cancer cells in vitro 2002 ·Bone ·Ingunn Holen, Peter I. Croucher, Anthony C. Evans, J M Lippitt, Freddie C. Hamdy, RE Coleman, Colby L. Eaton	1
10	The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests 2000 ·Cancer ·Lawrence B. Marks, Donna Hollis, Michael T. Munley, Gunilla C. Bentel, Melahat Garipağaoğlu, Ming Fan, (unknown), Robert Clough, Gregory S. Sibley, RE Coleman, R.J. Jaszczak	2
11	AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282) 2000 ·Ghent University Academic Bibliography (Ghent University) ·M. Piccart, (unknown), P.F. Bruning, RE Coleman, (unknown), Teresa Gamucci, C.J. Twelves, Luc Duchateau, Laura Biganzoli, (unknown), (unknown), Ron Epelbaum	13
12	Prospective investigation of positron emission tomography in lung nodules. 1998 ·Journal of Clinical Oncology ·Val J. Lowe, James W. Fletcher, Lisa S. Gobar, Michael Lawson, Peter T. Kirchner, Peter E. Valk, John P. Karis, Karl F. Hübner, Dominique Delbeke, (unknown), Edward F. Patz, RE Coleman	407
13	Clinical PET in Oncology 1998 ·PubMed ·RE Coleman	51
14	Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. 1997 ·Journal of Clinical Oncology ·J. Vinholes, Chun Guo, O.P. Purohit, Richard Eastell, RE Coleman	58
15	Chronic CSF Leak Into the Peritoneal Cavity Shown by Radionuclide Cisternography: 1997 ·Clinical Nuclear Medicine ·David M. Ashley, RE Coleman, Herbert E. Fuchs, Guy de L. Dear, Brian Ginsberg, (unknown), Henry S. Friedman, (unknown)	4
16	Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography 1995 ·The Annals of Thoracic Surgery ·Francis G. Duhaylongsod, Val J. Lowe, Edward F. Patz, Anna Vaughn, RE Coleman, Walter G. Wolfe	189
17	The role of the autonomic nervous system in sudden cardiac death 1992 ·Trends in Cardiovascular Medicine ·J. Marcus Wharton, RE Coleman, Harold C. Strauss	28
18	Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry 1989 ·British Journal of Cancer ·C.J. Twelves, (unknown), RE Coleman, MA Richards, RD Rubens	26
19	Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) 1988 ·British Journal of Cancer ·RE Coleman, Penella J. Woll, M. P. Miles, (unknown), RD Rubens	107
20	Comparison of iodine monochloride and modified chloramine-T radioiodination for in vivo protein studies. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), RE Coleman, Linda A. Sherman	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact